GDF-15 and IL-6 track healthy aging in older adults living with HIV
In 247 adults aged 65+ with suppressed HIV, higher GDF-15 and IL-6 tracked with poorer healthy-aging scores, while CRP and D-dimer did not.
Summary
As people with HIV live longer, there is no validated biomarker for how well they are aging. Researchers measured four inflammatory markers (CRP, D-dimer, GDF-15, IL-6) in 247 Canadians aged 65 or older whose HIV was well controlled. They compared the results with the Rotterdam Healthy Aging Score, a 14-point composite of chronic disease, mood, cognition, function, pain, social support and life satisfaction. Higher GDF-15 and IL-6 were linked to lower scores (Spearman rho -0.35 and -0.27). The links held after adjusting for age, sex, race, BMI, years with HIV and nadir CD4 count. Both markers also tracked with frailty, and GDF-15 with lower cognitive scores. CRP and D-dimer showed no association. The associations were modest and cross-sectional, so these markers are candidates for further testing, not clinical tools yet.
Detailed Summary
Antiretroviral therapy has pushed the median age of people living with HIV in high-income countries toward 65. Despite near-normal life expectancy, this group carries more comorbidity, frailty and lower quality of life. No HIV-specific biomarker exists to monitor healthy aging or to serve as a trial endpoint. Mortality and hospitalization endpoints require large, long, costly trials and miss the multidimensional nature of aging, so a blood marker that tracks health could be useful.
This analysis used a sub-study of CHANGE HIV, a Canadian cohort of adults aged 65 or older living with HIV. From 268 consenting participants in Toronto and Montreal, 247 remained after exclusions (incomplete data, untested samples, and one person with viral load above 200 copies/mL). Baseline serum CRP, D-dimer, GDF-15 and IL-6 were measured with an automated ELISA platform. They were compared mainly with the Rotterdam Healthy Aging Score (HAS, 0–14, higher is healthier) using Spearman correlation and multivariable regression on log-transformed markers. Secondary measures were frailty (Fried phenotype), cognition (MoCA), self-rated health (EQ-5D VAS), social support and loneliness.
Participants were mostly white (79%) men (92%) with a median age of 72 and about 31 years of living with HIV. Median HAS was 12. Median GDF-15 was 1810 pg/mL and median IL-6 was 3.49 pg/mL. GDF-15 (rho -0.35, 95% CI -0.45 to -0.24) and IL-6 (rho -0.27, 95% CI -0.39 to -0.15) were inversely correlated with HAS (both p<0.001). CRP and D-dimer were not (rho about -0.03 and -0.05). In adjusted models, each one-point higher HAS corresponded to about 0.06 lower log GDF-15 and 0.07 lower log IL-6. Age strongly predicted GDF-15, but the HAS association remained. Both markers were also positively correlated with frailty (rho about 0.20 and 0.19). GDF-15 was linked to lower MoCA scores, and IL-6 to lower self-rated health. Neither was linked to social support or loneliness.
The authors suggest GDF-15 and IL-6 merit further evaluation as biomarkers of healthy aging in older people with HIV. They could eventually be used to monitor patients or as intermediate endpoints in intervention trials. GDF-15 is of particular interest because it reflects stress responses linked to mitochondrial dysfunction and neurodegeneration, and anti-GDF-15 therapies are in early development for cachexia. It is unclear whether lowering GDF-15 would help in aging or HIV.
The findings are preliminary. The design is cross-sectional, so it cannot show whether the markers predict future decline or respond to interventions. The correlations are modest, and the cohort is predominantly white, male and Canadian. There is no HIV-negative comparator, and no formal test of whether the markers add information beyond age or existing measures.
Key Findings
- Higher GDF-15 correlated with lower Healthy Aging Score (rho -0.35, p<0.001), the strongest association among the four markers tested.
- Higher IL-6 also correlated with lower Healthy Aging Score (rho -0.27, p<0.001); CRP and D-dimer showed no association.
- GDF-15 and IL-6 associations with healthy aging persisted after adjusting for age, sex, race, BMI, years with HIV and nadir CD4.
- Both GDF-15 and IL-6 correlated with frailty (rho ~0.20); GDF-15 also correlated with lower MoCA cognitive scores.
- Neither marker related to social support or loneliness, suggesting they reflect biological and functional health more than psychosocial status.
Methodology
Cross-sectional analysis of baseline data from 247 adults aged 65+ with suppressed HIV in the prospective CHANGE HIV cohort (Toronto and Montreal sites). Serum CRP, D-dimer, GDF-15 and IL-6 were measured by automated ELISA and compared with the Rotterdam Healthy Aging Score via Spearman correlation and multivariable regression on log-transformed markers. Secondary outcomes were frailty, MoCA, EQ-5D VAS, social support and loneliness.
Study Limitations
The cross-sectional design precludes conclusions about prediction or causality, and the correlations were modest. The sample was mostly white, male and Canadian with controlled HIV, and had no HIV-negative controls. Some data were missing, some CRP and D-dimer values fell outside assay limits, and no correction for multiple comparisons was reported. Summary figures also differ slightly between the abstract and tables (for example CRP and D-dimer medians, and age range).
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
